Shadow mentoring: a cost–benefit review for reform
Brionna Davis-Reyes(Yale University), Christina M. Termini(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Antentor Hinton(Vanderbilt University), Aileen I. Fernandez(Yale University), Terika McCall(Yale University), C.A. Starbird(University of North Carolina Health Care)
Cited by 20
Related Papers
Examination of Low ERBB2 Protein Expression in Breast Cancer Tissue
|JAMA Oncology|2022|347
Deep learning trained on hematoxylin and eosin tumor region of Interest predicts HER2 status and trastuzumab treatment response in HER2+ breast cancer
|Modern Pathology|2021|166
Quantitative measurement of HER2 expression to subclassify ERBB2 unamplified breast cancer
|Laboratory Investigation|2022|141
Multi-institutional Assessment of Pathologist Scoring HER2 Immunohistochemistry
|Modern Pathology|2023|98